Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

This study has been completed.
Sponsor:
Collaborator:
Astex Pharmaceuticals
Information provided by:
Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT00144430
First received: August 31, 2005
Last updated: February 2, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
No publications provided by Ann & Robert H Lurie Children's Hospital of Chicago

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):